No, GLP-1 receptor agonists are not approved for treating Hashimoto's thyroiditis and lack clinical evidence supporting their use for autoimmune thyroid disease
This rebound effect shows that the drug was working well to manage their obesity, but when they stopped using it, the weight returnedmuch like what would happen to someone with elevated blood pressure or high cholesterol
However, this meta-analysis included only one RCT 43 and one case-control study 51 for GLP-1RAs (but not the more recent semaglutide) 41
In trial settings, researchers monitor gastrointestinal events closely because they can affect tolerability, participant continuation and interpretation of study outcomes
If you have obesity-related conditionssuch as type 2 diabetes, hypertension, or sleep apneastarting now with an approved injectable GLP-1 may make sense
GLP-1 weight-loss capsules Stimulate the satiety hormone GLP-1 and support your weight loss with Essentials GLP-1 Active
